Irodalom:
1. Ogino S, Goel A.: Molekular classification and correlates in colorectal cancer. J Molec Diagn 10:13-27, 2008
2. Sjöblom T, Jones S, Wood LD, et al: The consensus coding sequences of human breast and colorectal
cancers. Science 314:268-274, 2006
3. Sjöblom T, Jones S, Wood LD, et al: The consensus coding sequences of human breast and colorectal
cancers. Sicence 314-268-274, 2007
4. Nosho K, Yamamoto H, Adachi Y, et al: Gene expression profiling of colorectal adenocarcinomas and
early invasive carcinomas by cDNA array analysis. Br J Cancer 92:1193-1200, 2005
5. Bianchini M, Levy E, Zucchini C, et al: Comparative study of gene expression by cDNA microarray in
human colorectal cancer tissues and normal mucosa. Int J Oncol 29:83-94, 2006
6. Grade M, Hörmann P, Becker S, et al: Gene expression profiling reveals a massive, anauploidy-dependent
transcriptional deregulation and distinct differences between lymph node-negative and lymph
node-positive colon carcinomas. Cancer Res 67:41-56, 2007
7. Grade M, Ghadimi BM, Varma S, et al: Aneuploidy-dependent massive deregulation of the cellular
transcriptome and apparent divergence of the Wnt/b-catenin signaling pathway in human rectal carcinomas.
Cancer Res 66:267-282, 2006
8. Zlobec I, Baker K, Minoo P, et al: Node-negative colorectal cancer at high risk of distant metastasis
identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein
expression. Clin Cancer Res 14:143-148, 2008
9. Lin YH, Friederichs J, Black MA, et al: Multiple gene expression classifiers from different array platforms
predict poor prognosis of colorectal cancer. Clin Cancer Res 13:498-507, 2007
10. Eschrich S, yang I. Bloom G, et al: Molecular staging for survival prediction of colorectal cancer
patients. J Clin Oncol 23:3526-3535, 2005
11. Ki DH, Jeung HC, Park CH, et al: Whole genome analysis for liver metastasis gene signatures in
colorectal cancer. Int J Cancer 121:2005-2012, 2007
12. Kim JG, Chae YS, Sohn SK, et al: Vascular endothelial growth factor gene polymorphisms associated
with prognosis for patients with colorectal cancer. Clin Cancer Res 14:62-66, 2008
13. Galon J, Costes A, Sanchez-Cabo F, et al: Type, density, and location of immune cells within human
colorectal tumors predict clinical outcome. Science 313:1960-1964, 2006
14. Nagorsen D, Voigt S, Berg E, et al: Tumor-infiltrating macrophages and dendritic cells in human
colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated
antigens and survival. J Transl Med 5:62, 2007
A vastagbél 299
15. Kim GP Colangelo LH, Wieand HS, et al: A nagyfokú mikroszatellita-instabilitás prognosztikai és
prediktív szerepe vastagbélrákban: A National Cancer Institute és a National Surgical Adjuvant Breast
and Bowel Project közös vizsgálata. J Clin Oncol 3:127134, 2007
16. Moroni M, Veronese S, Benvenuti S, et al: Gene copy number for epidermal growth factor receptor
(EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol
6:279-286, 2005
17. Frattini M, Saletti P, Romagnani E, et al: PTEN loss of expression predicts cetuximab efficacy in
metastatic colorectal cancer patients. Br J Cancer 97:1139-1145, 2007
18. Sartore-Bianchi A, Moroni M, Veronese S, et al: Epidermal growth factor receptor gene copy number
and clinical outcome of metastatic colorectal cancer treated with panitumumab. J Clin Oncol 25:3238-
3245, 2007
19. Liévre A, Bachet J-B, Le Corre D, et al: KRAS mutation status is predictive of response to cetuximab
therapy in colorectal cancer. Cancer Res 66:3992-3995, 2006
20. Di Fiore F, Blanchard F, Charbonnier F, et al: Clinical relevance of KRAS mutation detection in
metastatic colorectal cancer treated by Cetuximab plus chemotherapy. Br J cancer 96:1166-1169, 2007
21. Khambata-Ford S, Garrett CR, Meropol NJ, et al: Expression of epiregulin and amphiregulin and K-ras
mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
J Clin Oncol 25:3230-3237, 2007
